News From Pharma Valley
JGL Once Again Among Equal Pay Champion Employers
For the third consecutive year, JGL’s commitment to fair and equal opportunities for all employees has been reaffirmed. The Company has been awarded the Equal Pay Champion certificate as part of the Selectio Equal Pay project, confirming that its approach to equality is not a one-off initiative but the result of consistent and continuous effort.
Alenka Jajac-Knez at the Panel Discussion Women in Science, Medicine and Pharmacy
Alenka Jajac-Knez, Chief Executive Officer of JGL, took part in the WiA Connect panel discussion organised by Women in Adria, held on 26 February 2026 in Zagreb.
Stable foundations for new opportunities and shared growth
JGL Group generated total revenue of EUR 306 million in 2025, representing a 22 per cent increase compared with the same period in 2024. Operating profit (EBITDA) amounted to EUR 60 million, up 34 per cent year on year, while profit before tax (EBT) rose by a strong 64 per cent to EUR 47 million.
JGL Awarded a Record €21 Million in Tax Incentives
For its manufacturing capacity expansion project, JGL has been awarded a record €21 million in tax incentives by the Ministry of Economy, in accordance with the Investment Promotion Act.